PharmaSeq

Home Company News & Events Press Releases 2013 NSF Awards SBIR Grant to PharmaSeq to Develop a “Radio p-Chip” for Intercellular sensing

Press Releases

NSF Awards SBIR Grant to PharmaSeq to Develop a “Radio p-Chip” for Intercellular sensing

Monmouth Junction, NJ, January 22, 2013. PharmaSeq, Inc. announced today the award of a Phase I Small Business Innovative Research (SBIR) grant from the National Science Foundation to develop a "radio p-Chip". This revolutionary device will be the first microchip with a sensor that can be injected into live cells, and transmit information from within without a physical connection.

The radio p-Chip will combine elements of PharmaSeq's laser light-activated p-Chip, a novel device that transmits the chip's serial number via radio signals, with enhancements to monitor events by adding a dielectric sensor. The on-board sensor will gather information about real-time physiological conditions in the cell and transmit it along with the serial number identifying the cell itself. The device envisioned is one part of a system incorporating, in addition to the radio p-Chip, a custom-designed receiver and antenna system, devices to implant the chip into cells, and associated firmware and application software. The goals of the work are to design and demonstrate a fully functional proof-of-principle 250 micron device and to then shrink it to smaller dimensions for implanting into living cells.

Dr. Richard G. Morris, CEO of PharmaSeq, Inc., said: "The successful completion of this project will have profound implications on future research with living cell systems in a wide variety of applications, including the readout of key physiological characteristics, ID-tagging of individual cells and tracking their history, tagging embryos, flow cytometry and process monitoring." Morris continues, "The radio p-Chip will be superior in both performance and cost and will address the needs of a broad range of investigators in cell biology. The development of a radio p-Chip will provide a powerful new tool for cell biology and in particular for the in vivo studying of a wide variety of human diseases and have implications for drug discovery and in vitro diagnostics."

For further information, please contact Dr. Richard G. Morris, CEO (morris@pharmaseq.com), or Dr. Wlodek Mandecki, President, at (732) 355-0100.


PharmaSeq, Inc.
11 Deer Park Drive, Suite 104
Monmouth Junction, NJ 08852


Find us on the web at: www.pharmaseq.com.


Home Company News & Events Press Releases 2013 NSF Awards SBIR Grant to PharmaSeq to Develop a “Radio p-Chip” for Intercellular sensing